Try our Advanced Search for more refined results
Health - October, 2011
213 articles
- Calif. Court Tosses Pay-For-Delay Suit Over Bayer's Cipro
- Hospital Operator Drops Insurer From Antitrust Suit
- NYC Pays $70M To Settle US Atty's Medicaid Abuse Suit
- Hospital Must Bargain With Nurses' Union: 9th Circ.
- Amylin Can't Block Lilly's Rival Drug Sales: 9th Circ.
- Cephalon Patent Found Invalid In Pay-For-Delay Case
- Insured Can't Appeal Cancer Coverage Ruling: Judge
- Data Breaches At NHS Occur At Alarming Rate: Report
- AstraZeneca, Pozen Want Generic Arthritis Drug Blocked
- Medical Device Preemption Case Rejected By High Court
- Obama Orders FDA Crackdown On Drug Shortages, Gouging
- Fed. Circ. Won't Rethink BD Syringe Patent Fight
- Divisive Teva-Merck IP Ruling Stays Out Of Supreme Court
- Globus Says Sales Rep Was Double Agent For Rival
- Trends In Long-Term Care Insurance
- High Court Vacates Generics Preemption Ruling
- Momenta Gets Rivals' Sale Of Generic Lovenox Barred
- Pfizer Failed To Warn Of Zoloft Birth Defect Risks: Suits
- Ex-Ky. Judge Disbarred Over $126M Fen-Phen Fees
- USC Focuses Ire On Eye Institute Over Lease Permits
- Pharmacies Bring Pfizer-Wyeth Merger Suit To High Court
- Coventry Nears Copay Case Deal On Eve Of Trial
- County Can't Pursue Own Avandia False Ad Claims: Judge
- Waste Co. Stericycle Says Ex-Sales Reps Stole Secrets
- HealthSpring Investor Tries To Halt Cigna Purchase
- Putting Teeth Into Falcon
- Avoiding Client Reference Fatigue During Awards Season
- Bristol-Myers Can't Shake Suit Over Kickbacks Scheme
- Yaz MDL Plaintiffs Say FDA Should See Confidential Docs
- Yaz, Other Birth Control Drugs Boost Blood Clot Risk: FDA
- House Passes Bill To Scale Down Medicaid Rolls
- BioMed Secures Tenant For I-270 Office
- Jury Awards Novozymes $18M In IP Fight With DuPont Unit
- Case Study: Merck V. Garza
- McKesson Pays $82M To End Drug Price Inflation Suit
- Astellas Drug Reps Get Initial Class Cert. In OT Case
- Bristol-Myers Faces Italian Scrutiny Over '90s Ops
- Barclays PE Snaps Up Swiss-Owned Chemical Co.
- Medtronic Catheter Side Effects Are Cause For Concern: US
- Investor Sues Google Directors Over Online Drug Sales
- Insurers Ask High Court To Hear Health Fight Quickly
- China's Global Pharm Scores $15M To Fund Future Buys
- You Cannot Sue For What They Cannot Do
- Merchant & Gould Adds Sutherland IP Pro To Atlanta Office
- Danisco Fails To Prove Novozymes Ethanol IP Invalid
- Olympus Head Steps Down Amid Merger Fee Scandal
- Stikeman Guides Cardinal Health's $162M Futuremed Buy
- GSK Hid Morning Sickness Drug's Birth Defect Risks: Suit
- 8th Circ. Won't Revive Minn. Prempro Suits
- Eli Lilly Settles Suit Over Generic Prozac Suicide Risk
- Omnicare Faces Fresh Suit Over Alleged Medicare Fraud
- Novartis Unit Subpoenaed In HHS Fraud Investigation
- Olympus Struggles To Survive Merger Fee Scandal
- The Curious Case Of Urology Of Central Pa.
- Eli Lilly Pulls 'Ineffective' Sepsis Drug Xigris
- Amerigroup Snaps Up Health Plus For $85M
- Penn Medicine, REIT Invest $72M In Hospital High-Rise
- Drug Cos. Made Record Pay-For-Delay Deals In 2011: FTC
- Ropes Helps Metalmark In Bostwick Labs Takeover
- Amgen To Pay $780M To Settle Drug Sales Suits
- FDA Raises Doubts Over Insufficient AtriCure Trial
- Software Co. Investors Can't Revive Suit Over Oracle Buy
- Imaging Co. Loses Sanctions, Dismissal Bid In FCA Suit
- Custom Software Not Covered By Consumer Law: NJ Court
- Bristol-Myers, Novartis Settle With Teva Over HIV Drug IP
- Biotronik Can't Seek $100M From J&J Over Stents: Judge
- Chantix No Riskier Than Nicotine Patch, Gum: Studies
- Olympus Faces FBI Probe Over $687M Merger Advisory Fee
- FTC Warns NY Against Joint Health Care Negotiation Plans
- HIPAA — Paper Law No More
- 9th Circ. Backs Insurer's Win In Ventana IP Defense Row
- South Korea Fines GSK $2.6M Over Pay-For-Delay Deal
- Alkermes, Jazz Aim To Block Torrent's Generic Luvox
- Cigna Buys HealthSpring For $3.8B With Davis Polk Help
- White Atty Sues Health Agency Over Minority GC Hire
- $11M MedQuest Penalty Upheld In False Claims Case
- Wyeth Shareholders Seek Class Cert. In Pristiq Suit
- Actavis, Mylan Can Use Expert's Word In Heart Drug MDL
- Sun Healthcare Didn't Pay Nursing Home Workers OT: Suit
- DLA Piper Life Sciences Partner Jumps To Fenwick
- Webster Puts Up $10M For Seavest Hospital Project
- OMERS PE Unit Picks Up String Of US Dental Centers
- Winston & Strawn Helps AAR Land Teleflex Units For $280M
- AMAG Shareholders Reject $268M Allos Merger
- Pros And Cons Of A CMS-FDA Parallel Review Program
- EU Scrutinizes J&J, Novartis Generic Painkiller Deals
- Pfizer Unit Off The Hook In Prempro Breast Cancer Case
- Abbott, Fournier Settle With Impax Over Generic Trilipix
- Fla. Appeals Court Nixes Ex-Hospital Chief's $10M Libel Win
- VC Firm Pursues Massive $250M Hospital Project In Texas
- Pfizer Pays $14.5M To End Whistleblowers' FCA Suit
- 8th Circ. Probes Plaintiffs' Standing In Health Law Suit
- Investor Says K-V Lied About Pregnancy Drug's Prospects
- Wyeth Sued Again Over Effexor Generics Delays
- Case Study: FTC V. Lundbeck
- Fed. Circ. Sides With Streck In Hematology Patent Fight
- Nomir, McDermott Bury $143M Patent Malpractice Suit
- Bayer Wins Dismissal Of RICO Claim In False Ad Fight
- Novartis Stuck With Sanctions In Bone Drug MDL
- DOJ, FTC Finalize Antitrust Rules For ACOs
- FDA Deems CareFusion Ventilator Defect High-Risk
- Novo Ramps Up Prandin IP Battle With Sandoz Suit
- Miller & Chevalier Adds Ex-Baxter Atty
- 9th Circ. Kills Some Mont. Insurance Claims Under HIPAA
- Abbott Labs Splits In Bid To Drive Growth
- Warner Chilcott Hits Watson With Atelvia Patent Suit
- Condom Maker's USAID Suit Premature, Judge Says
- Judge Tosses Elan Shareholder Suit Over $1B J&J Deal
- EU High Court Bans Patents For Embryonic Stem Cells
- Abbott, Lilly Fight Sales Reps' OT Claims In 7th Circ.
- Plumbers Cop To Kickbacks For Health Facility Work
- FDA Warns GSK Over Manufacturing Violations In UK
- FDA Chemist Pleads Guilty To $4M Insider Trading Plot
- Google, KPCB Join $33.5M Cancer Test Co. Infusion
- Fed. Circ. Nixes Apotex $108M Interest Payout Over Plavix
- Floundering Graceway Wins OK For Asset Auction
- Pfizer Wins Attys' Fees From Teva In Viagra Patent Row
- Severance In Multiplaintiff Pharmaceutical Cases
- Conceptus Scores $18.8M Victory In Hologic Patent Fight
- Ex-Alfacell Exec's Securities Suit Gets The Boot
- Alcon Sues Generics Maker Over Nasal Spray Patent
- Ametek Acquires Privately Held Eye Care Co. For $150M
- JPMorgan, BNY Mellon Sued Over Hospital Bond Filings
- Bausch & Lomb, Insurer Settle Infection Coverage Row
- Davis Polk Advises Roche In $230M Deal To Buy Anadys
- Cautioning Bilateral Monopoly Markets In Health Care
- GSK Settles Direct Buyers' Wellbutrin Claims For $49M
- US Dodges UnitedHealth Protest Of $24B Military Contract
- No Quick End For Dallas In Ex-Auditor's Retaliation Suit
- Innovative Corporate Counsel: Elpidio 'PD' Villarreal
- HHS Won't Pursue Health Care Law's CLASS Program
- J&J Unit Bests Suit Over Levaquin Injuries
- Teva, Cephalon Win EU Antitrust OK For $6.8B Tie-Up
- Pharma Co. Wants Ropes & Gray Atty Tossed From IP Suit
- Sens. Target FDA Regs To Speed Medical Device Review
- Amgen Asks 9th Circ. To Undo Shareholder Class Cert.
- Judge Nixes Suits Seeking Kagan Health Care Reform Docs
- Trust Can't Boot Abbott's Humira Patent Challenge
- SAIC Faces Class Action Over Tricare Data Breach
- Considering Contingency Fees In Jury Deliberations
- PPD Investor Sues Over $4B Carlyle, Hellman Buyout
- Noven Tries To Block Watson's Generic Daytrana
- Allos Settles Investor Suit Over $686M AMAG Tie-Up
- AstraZeneca, Sun Pharma Settle Over Nexium Generic
- Nemours Says Data Breach Affected 1.6M Patients
- Ex-Kan. AG Could Lose License After Abortion Probe
- Centurion Shores Up Biotech Outfit With $10M Investment
- Siemens, U. Of Neb. Settle Lab Test Patent Suit
- Judge Pares Solvay Drug Marketing Scheme Suit
- Antitrust Group Urges 8th Circ. To Rehear FTC Drug Suit
- Case Study: PharmAthene V. SIGA
- Bayer, Merial Hit With $32B Class Suit Over Flea Meds
- Allergan Sues Hi-Tech Over Pinkeye Drug Patents
- Teva, Baxter Told To Pay $104M In Propofol Hepatitis Case
- UK Watchdog Defines Probe Into Stericycle's Ecowaste Buy
- Pfizer, Actavis End Patent Fight Over Generic Lipitor
- Tricare, DOD Face Suit Over Theft Of 5M Patients' Data
- Case Study: In Re Lemington Home For The Aged
- Google, TPG, Others Invest $15M In DNA Data Firm
- SciClone Shells Out $2.5M To Investors Amid FCPA Probes
- Purdue Sues Ranbaxy Again Over Generic OxyContin
- Applied Scores Victory In Covidien Surgical Tool IP Fight
- FDA Tweaks Cancer Drug Warnings Over Hypertension Risk
- Amylin Calls For Lilly Marketing Injunction In 9th Circ.
- Seattle Genetics Insider's Brother Gets 18 Months
- Investor Says Stereotaxis Hid Problems With Products
- Drugmaker Takes FDA Generics Rule Fight To DC Circ.
- Teva Must Surrender Generics To Get Cephalon: FTC
- Momenta Stops Rivals' Generic Lovenox Launch For Now
- Simpson, Kirkland Aid Investors In $1.6B KCI Notes Deal
- HHS Urges DC Circ. To Keep Ban On OxyContin Misbranders
- Baxter To Exit Drug Price Inflation MDL For $30M
- Buchalter Nemer Adds Ropes & Gray Atty To Health Group
- Emdeon, Blackstone Seek To Quash Suit Over $3B Buyout
- The Downside Of Tort Reform
- Attorneys At Work: A Flexible Notion Of Plagiarism
- Pfizer Sues Watson Over Embeda Generic
- Prohibiting Genetic Discrimination In Calif.
- Paul Weiss Aids CI Capital In Interactive Health Buy
- A Creative Fix To A Medical Monopoly Problem
- SEC Sues Ex-Hansen Execs Over Fake Catheter Sales
- Catterton Seeks To Double Size Of Dental Implant Co.
- Krill Oil Extractor Neptune Sues Rivals Over New Patent
- Miraca To Buy US Clinical Lab Testing Co. For $725M
- NUHW President, Others Must Cover SEIU Legal Fees
- SAIC To Pay Alert Costs In Tricare Patient Data Breach
- Creabilis Raises $20M To Develop Dermatology Drugs
- AstraZeneca, Accord Settle Seroquel XR Patent Spat
- Web Pharmacies Sold Generics Under Celgene Marks: Suit
- Generics Cos. Rip AstraZeneca's Crestor IP In Fed. Circ.
- Verizon Can't Sue Over Robocalls: Health Product Cos.
- Relpax Patent Fight Revived After Stalled Settlement
- Impax Suit Against Pfizer Denied In IP Fight Over Detrol
- Jury Awards Man $48M For Extreme Reaction To Motrin
- Elan Again Beats Claims It Hid Drug Trial Data
- Pfizer Sued By Drugmaker Over Yanked Feed Additive
- Bid To Nix Hospital Antitrust Suit Is DOA In High Court
- Mispackaged Birth Control Pills Caused Pregnancy: Suit
- Straddling The Circuit Split On 'Filing Under Seal'
- Genzyme Gets Rival Pain Med Barred For Now In IP Row
- Ogletree Adds Ex-Duane Morris Atty In Philly
- Atty Impeded $188M Hospital Fraud Fine Collection: US
- FDA Pitches New Transparency, Social Media Plans
- Tucker Ellis Grabs 2 Jones Day Litigators In Cleveland
- 7th Circ. Overturns Affymax Foreign Patent Ruling
- Bringing ANDA Litigation To East Texas
- Shareholder Suit Over J&J Recall, Kickback Woes Tossed
- Jury Lets Merck Off Hook In Fosamax Bellwether Suit
- Mylan Can't Get Top Court Review Of $76M Antitrust Ruling
- Body Scan Co. Hit With Class Suit Over Shady Contracts
- Carlyle, Hellman To Take PPD Private For $3.9B
- Hanger Kicks Prosthetic Knee Antitrust Suit
- Clash Of The Class Action Law Firms